TrialJournal of experimental & clinical cancer research : CR2015

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer.

Bi-Yun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.